Showing Results for: “diabetes exercise”

The 80th Scientific Sessions will be held online June 12-16, 2020 The American Diabetes Association® (ADA) is excited to announce that the 80th Scientific Sessions will be transformed into a virtual conference! The meeting will be held online on June 12-16, 2020. We have shifted the format out of an abundance of caution and in the interest of protecting our employees and participants, many of whom have one or more factors that place them in the “higher risk” category for COVID-19. ADA’s leadership has determined that a virtual experience is the best way to ensure that our entire community of

The American Diabetes Association® applauds the Utah governor and legislature for passing HB 207 Recently, Utah Governor Gary Herbert signed into law American Diabetes Association-supported legislation capping monthly copayments for insulin at $30 for a 30-day supply. House Bill 207 (HB 207) also includes an emergency refill provision that will allow people without an up-to-date prescription to get insulin immediately rather than waiting until they are able to get a refill authorized by a physician, as well as a provision directing the Utah Department of Insurance to issue a report that

For people with type 2 diabetes (T2D) and chronic kidney disease (CKD), canagliflozin, an oral, sodium-glucose co-transporter-2 (SGLT2) inhibitor, has a renal- and cardiovascular-protective effect in reducing the progression of kidney impairment, according to the results of the CREDENCE trial presented today in a symposium at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco. In the first of several renal outcomes studies of SGLT2s, the landmark Canagliflozin and Renal Events in Diabetes with Established Nephropathy

Biden Administration Recognizes Obesity Drugs as Part of Covered Obesity Treatment in Proposed Rule Today the Centers for Medicare and Medicaid Services (CMS) announced they are rethinking the way the federal and state health care programs cover obesity treatment—recognizing obesity as a chronic disease. The Administration proposes to cover Food and Drug Administration (FDA) approved medications to reduce excess weight that leads to health conditions for Medicare Part D, Medicare Advantage and Medicaid beneficiaries who have obesity. Until now, breakthrough obesity medications were only

The American Diabetes Association ® (ADA) welcomes the 2025 principal officers and board of directors. The 15-member board comprises forward-thinking and innovative medical, scientific, education, and executive business professionals who will strategically lead and focus efforts to ensure the ADA continues to advance the mission upon which it was founded. "We are so excited to announce our 2025 board of directors,” said Charles “Chuck” Henderson, the ADA’s chief executive officer. “We look forward to the insight and skills each of these thought leaders will provide to help move the needle and

Today, The American Diabetes Association ® (ADA) announced its recognition as a winner in the 2022 Sharecare Awards in the category of chronic diseases for The Big Step Up: Detection that encourages people to take the big step up for their health. Sharecare (Nasdaq: SHCR ), in association with The National Academy of Television Arts & Sciences, New York Chapter (NY NATAS), the Sharecare Awards promote and reward excellence for the best productions and programming in health and well-being. Each year for Diabetes Awareness Month, the ADA curates a national campaign geared towards motivating

Jenna lives in Beverly Hills, Florida. She finds purpose by sharing her experience living with diabetes on TikTok.

Joe lives in West Allis, Wisconsin. He finds purpose in playing acoustic guitar (since age 8), biking, long distance walking, and working for the Department of Workforce Development.